Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Redburn Partners Initiates Coverage On Visa with Sell Rating

Redburn Partners Initiates Coverage On Visa with Sell Rating

Redburn Partners analyst Fahed Kunwar initiates coverage on Visa (NYSE:V) with a Sell rating.

byBenzinga Newsdesk

November 29, 2022

1 minute read

Redburn Partners analyst Fahed Kunwar initiates coverage on Visa (NYSE:V) with a Sell rating.

Oppenheimer Maintains Outperform on WillScot Mobile Mini, Raises Price Target to $53

By Benzinga Newsdesk

February 23, 10:09 AM

Oppenheimer analyst Scott Schneeberger maintains WillScot Mobile Mini (NASDAQ:WSC) with a Outperform and raises the price target from $51 to $53.

WSC

What’s Going On HSBC Shares Premarket Wednesday?

By Lekha Gupta

March 27, 7:47 AM

HSBC launches $150M Venture Debt offering in Singapore and $1B ASEAN Growth Fund, aiming to support high-growth companies and digital platform businesses.

AVIV

What’s Going On With Smartsheet Stock Thursday?

By Adam Eckert

June 8, 11:32 AM

Smartsheet Inc (NYSE: SMAR) shares are trading lower Thursday in the wake of the cloud based work management platform company's first-quarter results.

SMAR

Iovance Biotherapeutics Announces First Patient Dosed With PD-1 Inactivated Tumor Infiltrating Lymphocyte (TIL) Therapy

By Bill Haddad

October 10, 7:30 AM

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, announced that the first patient was dosed, and completed the safety observation

IOVA

Redburn Partners Initiates Coverage On Visa with Sell Rating

Related Posts

Oppenheimer Maintains Outperform on WillScot Mobile Mini, Raises Price Target to $53

What’s Going On HSBC Shares Premarket Wednesday?

What’s Going On With Smartsheet Stock Thursday?

Iovance Biotherapeutics Announces First Patient Dosed With PD-1 Inactivated Tumor Infiltrating Lymphocyte (TIL) Therapy